ARCHIVES

Sorafenib Targets AML Driven By Mutant FLT3 Gene

This article is from The Cancer Letter archive.

Vol. 31 No. 2 | February 29, 2008

Download PDF Visit The Full Archive

Related Articles

Spending Measures Include Provisions On Ethics For NIH Extramural Scientists.

July 11, 2008

Without Advance Directives, Families Prolong Treatment

April 27, 2001

Washington Braces For Oncologists; It’s The Spring Meetings

May 4, 1990

Lombardi Cancer Center, UDC Collaborate to Increase Cancer Awareness Among Blacks

August 3, 2001

Lombardi Recruits Adams-Campbell.

October 3, 2008

ACS Awards $54 Million in Research Grants.

October 31, 2008